Human clinical studies have shown that allergen immunotherapy reinvigorates the TFR cells in patients with allergic rhinitis, and the addition of human TFR cells in the TFH and B cell coculture system remarkably reduced TFH cell-promoted IgE production (70). The gene discussed is IGHE; the disease is allergic rhinitis.